Profile data is unavailable for this security.
About the company
NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
- Revenue in USD (TTM)2.85m
- Net income in USD-3.20m
- Incorporated2003
- Employees10.00
- LocationNanovibronix Inc525 Executive BlvdELMSFORD 10523United StatesUSA
- Phone+1 (914) 233-3004
- Websitehttps://nanovibronix.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invivo Therapeutics Holdings Corp | 0.00 | -9.33m | 1.24m | 6.00 | -- | 0.1387 | -- | -- | -3.53 | -3.53 | 0.00 | 2.87 | 0.00 | -- | -- | 0.00 | -81.32 | -73.69 | -94.35 | -85.63 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.01 | -- | 19.74 | -- |
| Escalon Medical Corp | 11.65m | -296.71k | 1.30m | 38.00 | -- | 1.26 | -- | 0.1114 | -0.0401 | -0.0401 | 1.29 | 0.2259 | 2.40 | 3.75 | 7.51 | 306,456.30 | -1.26 | -1.76 | -2.84 | -3.67 | 44.07 | 44.57 | -0.5265 | -0.9114 | 0.8927 | -1.62 | 0.1584 | -- | 13.80 | 1.33 | 760.89 | -17.06 | -19.85 | -- |
| Acutus Medical Inc | 9.55m | -9.70m | 1.32m | 233.00 | -- | -- | -- | 0.1382 | -0.3301 | 0.0956 | 0.3261 | -0.1353 | 0.1211 | 1.14 | 1.46 | 40,974.25 | -12.30 | -46.76 | -14.84 | -56.88 | -24.07 | -89.12 | -101.56 | -773.49 | 2.89 | -4.64 | 1.13 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| Nemaura Medical Inc | 0.00 | -10.65m | 1.40m | 36.00 | -- | -- | -- | -- | -0.3787 | -0.3787 | 0.00 | -0.6169 | 0.00 | 0.00 | -- | 0.00 | -117.49 | -58.18 | -- | -131.96 | -- | -- | -- | -7,384.83 | 0.0305 | -1.47 | 10.81 | -- | -84.71 | -- | -1.85 | -- | 64.14 | -- |
| Kelyniam Global Inc | 517.70k | -420.28k | 1.80m | 0.00 | -- | 3.36 | -- | 3.48 | -0.0253 | -0.0253 | 0.0312 | 0.0179 | 0.4135 | 7.04 | 4.38 | -- | -33.57 | -- | -41.79 | -- | 18.86 | -- | -81.18 | -- | 1.26 | -- | 0.6232 | -- | -26.47 | -- | -19.10 | -- | -- | -- |
| Bone Biologics Corp | 0.00 | -6.10m | 1.83m | 2.00 | -- | 0.4592 | -- | -- | -23.10 | -23.10 | 0.00 | 3.62 | 0.00 | -- | -- | 0.00 | -114.93 | -98.31 | -189.37 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
| Dynatronics Corp | 33.60m | -5.14m | 2.10m | 154.00 | -- | 0.2809 | -- | 0.0624 | -1.19 | -1.19 | 7.58 | 3.04 | 1.10 | 3.33 | 8.31 | 218,173.30 | -14.35 | -6.02 | -19.94 | -8.30 | 21.37 | 27.33 | -13.07 | -4.55 | 0.6787 | -12.56 | 0.2188 | -- | -8.41 | -8.81 | -19.84 | -- | -5.11 | -- |
| Aethlon Medical, Inc. | 574.25k | -12.26m | 2.21m | 15.00 | -- | 0.1491 | -- | 3.84 | -5.03 | -5.03 | 0.2362 | 2.93 | 0.0369 | -- | -- | 38,283.33 | -78.62 | -75.30 | -92.02 | -84.98 | -- | -- | -2,133.17 | -1,783.78 | -- | -- | 0.00 | -- | 95.21 | 30.86 | -15.55 | -- | 106.99 | -- |
| NanoVibronix Inc | 2.85m | -3.20m | 2.25m | 10.00 | -- | 0.6429 | -- | 0.7905 | -1.72 | -1.72 | 1.45 | 1.26 | 0.516 | 0.3683 | 13.64 | 285,000.00 | -57.98 | -116.16 | -101.17 | -169.36 | 68.98 | 50.47 | -112.35 | -570.47 | 1.38 | -13.47 | 0.00 | -- | 203.59 | 48.33 | 31.88 | -- | -34.02 | -- |
| Tivic Health Systems Inc | 1.13m | -7.61m | 2.55m | 9.00 | -- | 0.2819 | -- | 2.25 | -11.17 | -11.17 | 1.02 | 1.46 | 0.2184 | 0.9237 | 17.31 | 126,000.00 | -146.51 | -- | -194.55 | -- | 30.07 | -- | -670.99 | -- | 2.07 | -- | 0.00 | -- | -36.09 | -- | 18.34 | -- | -- | -- |
| Tenon Medical Inc | 3.21m | -14.33m | 2.62m | 21.00 | -- | 8.07 | -- | 0.8138 | -7.24 | -7.24 | 1.43 | 0.9724 | 0.4108 | 2.78 | 7.25 | 153,047.60 | -183.10 | -- | -269.43 | -- | 54.70 | -- | -445.77 | -- | 2.35 | -- | 0.00 | -- | 323.73 | -- | 17.63 | -- | -- | -- |
| InnerScope Hearing Technologies, Inc. | 334.45k | -7.15m | 2.67m | 24.00 | -- | -- | -- | 8.00 | -0.0153 | -0.0153 | 0.0002 | -0.0028 | 0.0955 | 3.93 | 1.71 | -- | -204.11 | -27.82 | -- | -94.53 | 17.79 | 58.17 | -2,138.50 | -42.13 | 0.0022 | -0.4232 | -- | -- | -- | 100.59 | -- | -- | 233.50 | -- |
| VirExit Technologies Inc | 0.00 | -1.80m | 2.84m | -- | -- | -- | -- | -- | -0.0932 | -0.113 | 0.00 | -0.0367 | 0.00 | -- | -- | -- | -6,103.43 | -- | -- | -- | -- | -- | -- | -- | -- | -3.66 | -- | -- | -100.00 | -- | 19.08 | -- | -- | -- |
| Vycor Medical Inc | 1.44m | -425.52k | 2.94m | 8.00 | -- | -- | -- | 2.04 | -0.0133 | -0.0135 | 0.0425 | -0.1078 | 1.59 | 0.6672 | 6.81 | 179,572.50 | -11.22 | -47.86 | -- | -- | 89.48 | 89.60 | -7.04 | -35.42 | 0.0861 | -0.0247 | -- | -- | 19.43 | -0.6542 | 46.49 | -- | -31.77 | -- |
| Invo Bioscience Inc | 4.25m | -7.08m | 3.28m | 25.00 | -- | -- | -- | 0.7709 | -5.68 | -5.68 | 2.59 | 0.0039 | 0.3473 | 9.50 | 30.72 | 169,953.20 | -57.87 | -94.63 | -128.00 | -151.45 | 39.90 | 74.91 | -166.64 | -343.11 | 0.1629 | -5.86 | 0.9965 | -- | 267.38 | 43.62 | 26.24 | -- | 87.09 | -- |
Data as of May 31 2024. Currency figures normalised to Nanovibronix Inc's reporting currency: US Dollar USD
13.35%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 24 Apr 2024 | 259.00k | 9.30% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 38.86k | 1.40% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 30.19k | 1.08% |
| Geode Capital Management LLCas of 31 Mar 2024 | 14.46k | 0.52% |
| AmTrust Financial Services, Inc. (Investment Portfolio)as of 31 Mar 2024 | 12.41k | 0.45% |
| Citadel Securities LLCas of 31 Mar 2024 | 10.65k | 0.38% |
| Tower Research Capital LLCas of 31 Mar 2024 | 6.06k | 0.22% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 16.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 10.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 31 Mar 2024 | 1.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
